8th October 2026
Boots has a new owner but this time the change of ownership comes with an important difference. The buyer is not another American private-equity group looking to restructure the business and eventually sell it on.
Boots is being bought by the Canadian branch of the wealthy Weston family, through its holding company Wittington Investments, in a deal worth about $8.9 billion (£6.7 billion), including debt.
The deal was announced on 7 October 2026 and is expected to complete in the first quarter of 2027, subject to regulatory approval.
So what happens to Britain's 1,800 Boots stores?
The short answer is that we don't yet know, but the new owners are talking about investment rather than an immediate programme of closures.
And that makes this takeover particularly interesting.
Who are the Weston family?
The Westons are one of Canada's best-known retail families.
Through Wittington and its associated businesses, they control Loblaw, Canada's largest grocery retailer, which in turn owns Shoppers Drug Mart, Canada's largest pharmacy, health and beauty business.
That experience could be particularly valuable at Boots.
Shoppers Drug Mart operates a model combining pharmacy, healthcare, beauty and general retail. Boots does much the same thing in Britain.
Wittington says it plans to invest in Boots by upgrading stores, improving its online operation and supporting the expansion of healthcare services.
That sounds rather different from simply buying a retailer, cutting costs and looking for the next buyer.
What exactly are they buying?
The transaction covers Boots' UK and Irish retail operations, Boots Opticians and the No7 Beauty Company, along with Boots' Thailand and franchised businesses.
The wider Boots Group's interests in Farmacias Benavides in Mexico and Alliance Healthcare Deutschland are staying with the existing owners.
Boots has more than 1,800 stores and employs more than 50,000 people across the UK and Ireland.
That makes it much more than a conventional high-street retailer.
For many communities, the Boots pharmacy is an important local healthcare service.
Will the stores close?
There is currently no announcement of a nationwide closure programme.
In fact, the public statement from Wittington points in the opposite direction, promising further capital investment, store upgrades and expansion of healthcare services.
That doesn't mean every Boots shop is guaranteed to remain open forever.
Retailers continually examine individual stores based on sales, rents, staffing, competition and local circumstances.
But there is an important difference between saying that individual stores may be reviewed and announcing a programme of widespread closures.
At the moment, the evidence points towards the former, not the latter.
The healthcare opportunity could be the biggest change
This may ultimately be more important than whether the shops get new floors or better lighting.
The Weston family already understands the pharmacy business through Shoppers Drug Mart.
And Britain's pharmacies are increasingly being asked to provide services that once would have involved a GP surgery or another part of the NHS.
Boots already provides services including vaccinations, pharmacy consultations and other healthcare services.
The new owners have specifically identified expansion of healthcare services as part of their plans.
That raises an interesting possibility.
Could Boots gradually become more of a healthcare provider and less dependent on selling cosmetics, toiletries and other retail goods?
If so, the Boots store of the future could look rather different from the Boots many people have known for decades.
There is also the online problem
Like almost every high-street retailer, Boots has to deal with changing shopping habits.
People can buy cosmetics, toiletries, medicines and many household products online.
The new owners have therefore said they want to improve the online experience as well as the physical stores.
That could mean better integration between the website, app and local shops.
Order online and collect locally.
Arrange a pharmacy service online.
Check whether a product is available before travelling.
Use the store primarily for healthcare while buying more routine products online.
The successful high-street pharmacy may increasingly be the one that combines the two.
Why has Boots changed hands so often?
This is perhaps the uncomfortable part of the story.
Boots has had several owners over the past two decades.
It was taken private with KKR backing in 2007, became part of Walgreens, and then became part of the Walgreens Boots Alliance group.
Sycamore Partners acquired the wider Walgreens Boots Alliance business in 2025 and subsequently separated Boots from the other businesses.
Now Boots is being sold again, only about a year later.
That is a lot of ownership change for a business whose strength is supposed to be its trusted name and long-term presence in communities.
The Westons are presenting their purchase differently.
They describe the opportunity as stable, long-term ownership, backed by further investment.
Whether that happens will be judged over several years rather than several quarters.
The Westons know British retail
The Canadian branch of the Weston family isn't completely new to Britain.
The family previously owned Selfridges, selling the department store group in 2022 for about £4 billion.
There is also a separate British branch of the Weston family behind Associated British Foods, the owner of Primark, Twinings and other brands.
So the family has considerable experience of British retail, although the Canadian and British Weston interests are separate businesses.
What does this mean for smaller towns?
This is perhaps where the takeover becomes particularly interesting.
In a large city, losing one pharmacy may be inconvenient because there are alternatives.
In a smaller town, a Boots pharmacy can be one of only a handful of easily accessible healthcare outlets.
That gives the 1,800-store network a value which isn't captured simply by looking at retail sales.
A store can sell shampoo and perfume, but it can also provide prescriptions, vaccinations, health advice and other services.
If the new owners really do expand healthcare provision, the local Boots could become more important to communities rather than less.
That could be particularly significant in rural areas where access to other healthcare services can involve considerable travel.
But there is a question for the new owners
The Westons are paying a lot of money for Boots.
So they will ultimately have to make the business generate an adequate return.
Investment in stores, technology and healthcare costs money.
Expanding services requires staff.
Keeping smaller stores open in communities where retail sales are relatively modest can also be expensive.
The challenge will therefore be balancing two things:
Boots as a commercial retailer
and
Boots as an important part of Britain's local healthcare infrastructure.
The two can work together, but they aren't automatically the same thing.
A different kind of Boots?
Perhaps the most interesting thing about this takeover is that the new owners have experience in exactly the area where Boots could have its biggest opportunity.
The Westons already own a major pharmacy business in Canada.
They know the combination of pharmacy + healthcare + beauty + retail.
They are also promising investment rather than simply talking about cost cutting.
That doesn't guarantee that every Boots store will survive or that prices will fall.
But it does suggest that the new owners see something more valuable in Boots than simply 1,800 shops.
They see a nationwide network of pharmacies and healthcare locations with a trusted name attached to them.
For customers, therefore, the question isn't simply:
"Will my local Boots still be there?"
It may eventually be:
"What will my local Boots actually become?"
And if the Weston family's Canadian experience is anything to go by, the answer could be a Boots that looks increasingly like a healthcare business with a retail operation attached, rather than simply a retailer with a pharmacy counter.